Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals

Research output: Contribution to journalReview articlepeer-review

Abstract

Substance abuse and addiction are highly prevalent in HIV-infected individuals. Substance abuse is an important comorbidity that affects the delivery and outcomes of HIV medical management. In this paper I will review data examining the associations between substance abuse and HIV treatment and potential strategies to improve outcomes in this population that warrant further investigation. Current - but not past - substance abuse adversely affects engagement in care, acceptance of antiretroviral therapy, adherence with therapy, and long-term persistence in care. Substance abuse treatment appears to facilitate engagement in HIV care, and access to evidence-based treatment for substance abuse is central to addressing the HIV epidemic. Strategies that show promise for HIV-infected substance abusers include integrated treatment models, directly observed therapy, and incentive-based interventions.

Original languageEnglish (US)
Pages (from-to)948-952
Number of pages5
JournalLife Sciences
Volume88
Issue number21-22
DOIs
StatePublished - May 23 2011

Keywords

  • Addiction
  • Adherence
  • HIV infection
  • Substance abuse

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals'. Together they form a unique fingerprint.

Cite this